Drug Report History #103730
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v11-FR | Version v2-FR | |
|---|---|---|
| Language | French | French |
| Date Updated (Changed) | Updated to: 2022-03-03 | Was: 2020-01-20 |
| Drug Identification Number | 02265990 | 02265990 |
| Brand name | VINORELBINE INJECTION | VINORELBINE INJECTION |
| Common or Proper name | Vinorelbine Injetion | Vinorelbine Injetion |
| Company Name | FRESENIUS KABI CANADA LTD | FRESENIUS KABI CANADA LTD |
| Ingredients (Changed) | Updated to: VINORELBINE | Was: |
| Strength(s) (Changed) | Updated to: 10MG | Was: |
| Dosage form(s) (Changed) | Updated to: SOLUTION | Was: |
| Route of administration (Changed) | Updated to: INTRAVENOUS | Was: |
| Packaging size | 1 ml | 1 ml |
| Additional packaging sizes | ||
| ATC code (Changed) | Updated to: L01CA | Was: |
| ATC description (Changed) | Updated to: PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS | Was: |
| Reason for shortage | Other (Please describe in comments) | Other (Please describe in comments) |
| Anticipated start date (Changed) | Updated to: | Was: 2020-01-20 |
| Actual start date (Changed) | Updated to: 2017-12-14 | Was: |
| Estimated end date (Changed) | Updated to: 2021-11-29 | Was: 2020-03-31 |
| Actual end date (Changed) | Updated to: 2021-06-01 | Was: |
| Shortage status (Changed) | Updated to: Resolved | Was: Anticipated shortage |
| Tier 3 Status | No | No |
| Company comments (Changed) | Updated to: Old DIN has been moved to Dormant- New DIN (02511347) to be made available November 29, 2021 | Was: Not Available |
| Health Canada comments |